On October 29, 2018, RWC-340B leaders met with George Sigounas, M.S., Ph.D., the HRSA Administrator, and Beth Nelson, HHS Health Policy Advisor, to advocate to
On Monday, Health and Human Services Secretary Alex Azar announced a proposed rule that would require pharmaceutical manufacturers to disclose wholesale acquisition cost (“WAC”) prices
On Wednesday, October 3, the U.S. Senate approved H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (“SUPPORT”) for Patients and Communities
